Literature DB >> 15068806

Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins.

Prasanna Venkatraman1, Ronald Wetzel, Motomasa Tanaka, Nobuyuki Nukina, Alfred L Goldberg.   

Abstract

Long glutamine sequences (polyQ) occur in many cell proteins, and several neurodegenerative diseases result from expansion of these sequences. PolyQ-containing proteins are degraded by proteasomes, whose three active sites prefer to cleave after hydrophobic, basic, or acidic residues. We tested whether these particles can digest a polyQ chain. Eukaryotic 26S and 20S proteasomes failed to cut within stretches of 9-29Q residues in peptides. While digesting a myoglobin Q(35) fusion protein, the proteasomes spared the polyQ sequence. In contrast, archaeal proteasomes, whose 14 active sites are less specific, rapidly digested such polyQ repeats. Therefore, when degrading polyQ proteins, eukaryotic proteasomes must release aggregation-prone polyQ-containing fragments for further hydrolysis by unidentified peptidases. In polyQ diseases, such polyQ sequences (38-300Qs) exceed the lengths of normal proteasome products (2-25 residues). Occasional failure of these long undegradable sequences to exit may interfere with proteasome function and help explain why longer polyQ expansions promote early disease onset.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15068806     DOI: 10.1016/s1097-2765(04)00151-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  132 in total

1.  A ubiquitin ligase-associated chaperone holdase maintains polypeptides in soluble states for proteasome degradation.

Authors:  Qiuyan Wang; Yanfen Liu; Nia Soetandyo; Kheewoong Baek; Ramanujan Hegde; Yihong Ye
Journal:  Mol Cell       Date:  2011-06-24       Impact factor: 17.970

2.  Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease.

Authors:  Juliette D Godin; Ghislaine Poizat; Miriam A Hickey; Florence Maschat; Sandrine Humbert
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

Review 3.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

4.  Inefficient degradation of truncated polyglutamine proteins by the proteasome.

Authors:  Carina I Holmberg; Kristine E Staniszewski; Kwame N Mensah; Andreas Matouschek; Richard I Morimoto
Journal:  EMBO J       Date:  2004-10-07       Impact factor: 11.598

Review 5.  Mapping molecular memory: navigating the cellular pathways of learning.

Authors:  Gavin R Owen; Elisabeth Anne Brenner
Journal:  Cell Mol Neurobiol       Date:  2012-04-10       Impact factor: 5.046

Review 6.  Current understanding on the pathogenesis of polyglutamine diseases.

Authors:  Xiao-Hui He; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 7.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

8.  Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease.

Authors:  Siddhartha Mitra; Andrey S Tsvetkov; Steven Finkbeiner
Journal:  J Biol Chem       Date:  2008-12-10       Impact factor: 5.157

9.  p62 plays a protective role in the autophagic degradation of polyglutamine protein oligomers in polyglutamine disease model flies.

Authors:  Yuji Saitoh; Nobuhiro Fujikake; Yuma Okamoto; H Akiko Popiel; Yusuke Hatanaka; Morio Ueyama; Mari Suzuki; Sébastien Gaumer; Miho Murata; Keiji Wada; Yoshitaka Nagai
Journal:  J Biol Chem       Date:  2014-12-05       Impact factor: 5.157

Review 10.  The ubiquitin-proteasome pathway in Huntington's disease.

Authors:  Steven Finkbeiner; Siddhartha Mitra
Journal:  ScientificWorldJournal       Date:  2008-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.